About: http://data.cimple.eu/news-article/57c20de936577925d1d6d5e908ea3f28bef6d31e10ba8a1ef86e2510

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: http://data.cimple.eu/news-article/57c20de936577925d1d6d5e908ea3f28bef6d31e10ba8a1ef86e2510 Goto Sponge NotDistinct Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

Attributes	Values
rdf:type	schema:NewsArticle
schema:articleBody	French pharmaceuticals giant Sanofi, under fire for a delay in its Covid-19 vaccine, reported Friday much higher 2020 earnings and a bigger shareholder payout. It said net profit jumped to 12.3 billion euros from 2.8 billion euros in 2019, boosted by a one-time gain of more than 7.0 billion euros from the sale of shares in Regeneron, the US firm leading the pack in antibody treatments for Covid-19. The board proposed paying a dividend of 3.20 euros a share or more than 4.0 billion euros in all. The healthy financial performance of the group contrasts with its poor public image in France following a PR debacle surrounding its work developing a vaccine against coronavirus. In May last year, its British CEO Paul Hudson said the United States would get its jabs before the rest of the world because of Washington's investment in its research, sparking fierce criticism in France. In the end, the group says it will have its candidate ready only at the end of 2021 and it has announced plans to help rivals Pfizer-BioNTech produce their world-leading innoculation. The group's cost-cutting measures, including in its research and development teams in France, have also been criticised in the media and by many French political figures. In its results statement, the group said it had saved around 1.7 billion euros with cuts last year, around 60 percent of which has been re-invested. Sanofi, a leading manufacturer of vaccines worldwide, said sales of the products had increased by nearly 9.0 percent to 6.0 billion euros last year, with a 38 percent increase in demand for flu jabs. lem-adp/bmm
schema:headline	France's under-fire Sanofi reports profit, dividend boost
schema:mentions	Washington Mystics Dividend French language Antibody Influenza Chief executive officer France United Kingdom Vaccine United States Severe acute respiratory syndrome coronavirus 2 Coronavirus disease 2019 Hudson Motor Car Company Sanofi
schema:author	http://data.cimple.eu/organization/1f0054d541e000623a2c1e561a247c073ef6328e8be9ffafda7b3fcd
schema:datePublished	2021-02-05 (xsd:date)
http://data.cimple...sPoliticalLeaning	other political leaning
http://data.cimple...logy#hasSentiment	positive sentiment
http://data.cimple...readability_score	60 (xsd:integer)

Faceted Search & Find service v1.16.115 as of Oct 09 2023

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3238 as of Jul 16 2024, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 3 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software